Lixte Biotechnology Holdings, Inc.
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on Lixte Biotechnology Holdings, Inc.
Scrip
• By Andy Smith
New Year, Same Issues The New Year often brings out the optimist in investors, especially in health care, where the build-up to the annual J.P. Morgan Healthcare conference in San Francisco includes p
Scrip
• By Mandy Jackson
Biopharmaceutical company initial public offerings appear to be getting back to their rapid 2020 pace with three IPOs launched in the US during the first week of December. Silverback Therapeutics, In
Scrip
• By Mandy Jackson
The question of where former Allergan plc CEO Brent Saunders would land next after the company was sold to AbbVie Inc. earlier this year for $63bn was answered in a 10 September filing with the US